Novel alginate three-dimensional static and rotating culture systems for effective ex vivo amplification of human cord blood hematopoietic stem cells and in vivo functional analysis of amplified cells in NOD/SCID mice

Transfusion

Volumn 53, Issue 9, 2013, Pages 2001-2011

  Yuan, Yan ^a   Sin, Wai Yee ^a   Xue, Bofu ^a   Ke, Yan ^a   Tse, Kai Tai ^a   Chen, Zi ^a   Xie, Yi ^a   Xie, Yong ^a  

^a HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CD34 SELECTION; CELL COUNT; CELL CULTURE; CELL ENCAPSULATION; COLONY FORMING CELL; CULTURE TECHNIQUE; EX VIVO STUDY; FLOW CYTOMETRY; FUNCTIONAL ASSESSMENT; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NOD SCID MOUSE; NONHUMAN; STEM CELL EXPANSION; THREE DIMENSIONAL IMAGING; UMBILICAL CORD BLOOD; XENOGRAFT;

ANIMALS; ANTIGENS, CD34; CELL CULTURE TECHNIQUES; CELLS, CULTURED; FEMALE; FETAL BLOOD; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; MICE, INBRED NOD; MICE, SCID; PREGNANCY;

EID: 84883867359     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12103     Document Type: Article

References (32)

1. Chao NJ, Emerson SG, Weinberg KI,. Stem cell transplantation (cord blood transplants). Hematology Am Soc Hematol Educ Program 2004: 354-371.
2. Tyndall A, Saccardi R,. Haematopoietic stem cell transplantation in the treatment of severe autoimmune disease: results from phase I/II studies, prospective randomized trials and future directions. Clin Exp Immunol 2005; 141: 1-9.
3. Marmont AM,. Stem cell transplantation for severe autoimmune diseases: progress and problems. Haematologica 1998; 83: 733-743.
4. Dazzi F, van Laar JM, Cope A, Tyndall A,. Cell therapy for autoimmune diseases. Arthritis Res Ther 2007; 9: 206.
5. Abdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, Zuba-Surma EK, Al-Mallah M, Dawn B,. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 989-997.
6. Assmus B, Honold J, Schachinger V, Britten MB, Fischer-Rasokat U, Lehmann R, Teupe C, Pistorius K, Martin H, Abolmaali ND, Tonn T, Dimmeler S, Zeiher AM,. Transcoronary transplantation of progenitor cells after myocardial infarction. N Engl J Med 2006; 355: 1222-1232.
7. Schachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Hölschermann H, Yu J, Corti R, Mathey DG, Hamm CW, Süselbeck T, Assmus B, Tonn T, Dimmeler S, Zeiher AM,; REPAIR-AMI Investigators. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med 2006; 355: 1210-1221.
8. Plett PA, Frankovitz SM, Orschell CM,. Distribution of marrow repopulating cells between bone marrow and spleen early after transplantation. Blood 2003; 102: 2285-2291.
9. Brown JA, Boussiotis VA,. Umbilical cord blood transplantation: basic biology and clinical challenges to immune reconstitution. Clin Immunol. 2008; 127: 286-297.
10. Cohen Y, Nagler A,. Cord blood biology and transplantation. Isr Med Assoc J 2004; 6: 39-46.
11. Gluckman E, Rocha V, Arcese W, Michel G, Sanz G, Chan KW, Takahashi TA, Ortega J, Filipovich A, Locatelli F, Asano S, Fagioli F, Vowels M, Sirvent A, Laporte JP, Tiedemann K, Amadori S, Abecassis M, Bordigoni P, Diez B, Shaw PJ, Vora A, Caniglia M, Garnier F, Chevret S, Eurocord Group. et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol 2004; 32: 397-407.
12. Migliaccio AR, Adamson JW, Stevens CE, Dobrila NL, Carrier CM, Rubinstein P,. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity. Blood 2000; 96: 2717-2722.
13. Fietz T, Berdel WE, Rieder H, Reufi B, Hopp H, Thiel E, Knauf WU,. Culturing human umbilical cord blood: a comparison of mononuclear vs CD34+ selected cells. Bone Marrow Transplant 1999; 23: 1109-1115.
14. Piacibello W, Sanavio F, Garetto L, Severino A, Bergandi D, Ferrario J, Fagioli F, Berger M, Aglietta M,. Extensive amplification and self-renewal of human primitive hematopoietic stem cells from cord blood. Blood 1997; 89: 2644-2653.
15. Piacibello W, Sanavio F, Garetto L, Severino A, Dané A, Gammaitoni L, Aglietta M,. Differential growth factor requirement of primitive cord blood hematopoietic stem cell for self-renewal and amplification vs proliferation and differentiation. Leukemia 1998; 12: 718-727.
16. Rice A, Flemming C, Case J, Stevenson J, Gaudry L, Vowels M,. Comparative study of the in vitro behavior of cord blood subpopulations after short-term cytokine exposure. Bone Marrow Transplant 1999; 23: 211-220.
17. Hofmeister CC, Zhang J, Knight KL, Le P, Stiff PJ,. Ex vivo expansion of umbilical cord blood stem cells for transplantation: growing knowledge from the hematopoietic niche. Bone Marrow Transplant 2007; 39: 11-23.
18. Ehring B, Biber K, Upton TM, Plosky D, Pykett M, Rosenzweig M,. Expansion of HPCs from cord blood in a novel 3D matrix. Cytotherapy 2003; 5: 490-499.
19. Kim HS, Lim JB, Min YH, Lee ST, Lyu CJ, Kim ES, Kim HO,. Ex vivo expansion of human umbilical cord blood CD34+ cells in a collagen bead-containing 3-dimensional culture system. Int J Hematol 2003; 78: 126-132.
20. Yuan Y, Tse KT, Sin FW, Xue B, Fan HH, Xie Y, Xie Y,. Ex vivo amplification of human hematopoietic stem and progenitor cells in an alginate three-dimensional culture system. Int J Lab Hematol 2011; 33: 516-525.
21. Wee S, Gombotz WR,. Protein release from alginate matrices. Adv Drug Deliv Rev 1998; 31: 267-285.
22. Magyar JP, Nemir M, Ehler E, Suter N, Perriard JC, Eppenberger HM,. Mass production of embryoid bodies in microbeads. Ann N Y Acad Sci 2001; 944: 135-143.
23. Oca-Cossio J, Simpson NE, Han Z, Stacpoole PW, Constantinidis I,. Effects of alginate encapsulation on mitochondrial activity. J Mater Sci Mater Med 2005; 16: 521-524.
24. Koch S, Schwinger C, Kressler J, Heinzen C, Rainov NG,. Alginate encapsulation of genetically engineered mammalian cells: comparison of production devices, methods and microcapsule characteristics. J Microencapsul 2003; 20: 303-316.
25. Zhang XB, Li K, Fok TF, Li CK, James AE, Lam AC, Lee SM, Yuen PM,. Cobblestone area-forming cells, long-term culture-initiating cells and NOD/SCID repopulating cells in human neonatal blood: a comparison with umbilical cord blood. Bone Marrow Transplant 2002; 30: 557-564.
26. Drouet M, Herodin F, Norol F, Mourcin F, Mayol JF,. Cell cycle activation of peripheral blood stem and progenitor cells expanded ex vivo with SCF, FLT-3 ligand, TPO, and IL-3 results in accelerated granulocyte recovery in a baboon model of autologous transplantation but G0/G1 and S/G2/M graft cell content does not correlate with transplantability. Stem Cells 2001; 19: 436-442.
27. Levac K, Karanu F, Bhatia M,. Identification of growth factor conditions that reduce ex vivo cord blood progenitor expansion but do not alter human repopulating cell function in vivo. Haematologica 2005; 90: 166-172.
28. Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ,. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin- cells with preserved ability to engraft SCID-hu bone. Blood 1998; 91: 1206-1215.
29. Ryu KH, Shin HY, Ahn HS, Kim YJ, Woo SY, Seoh JY,. Comparison of efficiency of ex vivo expansion of whole blood, mononuclear cells and purified CD34+ cells from human umbilical cord blood. Haematologica 2004; 89: 606-607.
30. Liu Y, Liu T, Fan X, Ma X, Cui Z,. Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel. J Biotechnol 2006; 124: 592-601.
31. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, Tennent B, McKenna S, Mobraaten L, Rajan TV, Greiner DL, et al. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995; 154: 180-191.
32. van der Loo JC, Hanenberg H, Cooper RJ, Luo FY, Lazaridis EN, Williams DA,. Nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mouse as a model system to study the engraftment and mobilization of human peripheral blood stem cells. Blood 1998; 92: 2556-2570.